ATE368739T1 - Vaskulärer endothelialer wachstumsfaktor x - Google Patents

Vaskulärer endothelialer wachstumsfaktor x

Info

Publication number
ATE368739T1
ATE368739T1 AT99968929T AT99968929T ATE368739T1 AT E368739 T1 ATE368739 T1 AT E368739T1 AT 99968929 T AT99968929 T AT 99968929T AT 99968929 T AT99968929 T AT 99968929T AT E368739 T1 ATE368739 T1 AT E368739T1
Authority
AT
Austria
Prior art keywords
growth factor
vascular endothelial
endothelial growth
angiogenesis
sequence
Prior art date
Application number
AT99968929T
Other languages
English (en)
Inventor
Robert Douglas Gordon
Jorg Jurgen Sprengel
Jeffrey Roland Yon
Josiena Johanna Huber Dijkmans
Anna Gosiewska
Sridevi N Dhanaraj
Jean Xu
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9828377.3A external-priority patent/GB9828377D0/en
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Application granted granted Critical
Publication of ATE368739T1 publication Critical patent/ATE368739T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
AT99968929T 1998-12-22 1999-12-21 Vaskulärer endothelialer wachstumsfaktor x ATE368739T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9828377.3A GB9828377D0 (en) 1998-12-22 1998-12-22 Vascular endothelial growth factor-e
US12496799P 1999-03-18 1999-03-18
US16413199P 1999-11-08 1999-11-08

Publications (1)

Publication Number Publication Date
ATE368739T1 true ATE368739T1 (de) 2007-08-15

Family

ID=27269595

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99968929T ATE368739T1 (de) 1998-12-22 1999-12-21 Vaskulärer endothelialer wachstumsfaktor x

Country Status (10)

Country Link
EP (1) EP1141293B1 (de)
AT (1) ATE368739T1 (de)
AU (1) AU778412B2 (de)
CA (1) CA2356009C (de)
DE (1) DE69936733T2 (de)
DK (1) DK1141293T3 (de)
ES (1) ES2291047T3 (de)
IL (1) IL143832A0 (de)
NZ (1) NZ512892A (de)
WO (1) WO2000037641A2 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69939374D1 (de) 1998-03-17 2008-10-02 Genentech Inc Zu vegf und bmp1 homologe polypeptide
US6432673B1 (en) 1998-12-07 2002-08-13 Zymogenetics, Inc. Growth factor homolog ZVEGF3
EP1710299A3 (de) * 1998-12-30 2007-01-10 Millennium Pharmaceuticals, Inc. Sekretierte Proteine und dafür kodierende Polynukleotide
WO2001032197A2 (en) * 1999-11-02 2001-05-10 Eli Lilly And Company Methods of using lp8, a pdgf-related protein, to treat musculoskeletal disorders
WO2002012334A2 (en) * 2000-08-07 2002-02-14 Zymogenetics, Inc. Snake venom polypeptide zsnk1
US7067317B2 (en) 2000-12-07 2006-06-27 Sangamo Biosciences, Inc. Regulation of angiogenesis with zinc finger proteins
AU2002228841C1 (en) 2000-12-07 2006-11-23 Sangamo Biosciences, Inc Regulation of angiogenesis with zinc finger proteins
IL157797A0 (en) 2001-03-09 2004-03-28 Janssen Pharmaceutica Nv Modulation of smooth muscle cell proliferation by vegf-x or antagonists
CN101392026B (zh) * 2008-10-09 2011-11-09 黄岚 用于预防和治疗纤维化类疾病以及肝癌的多肽

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998007832A1 (en) * 1996-08-23 1998-02-26 Ludwig Institute For Cancer Research Recombinant vascular endothelial cell growth factor d (vegf-d)
AU5439998A (en) * 1996-12-06 1998-06-29 Zymogenetics Inc. Vascular endothelial growth factor
WO1999037671A1 (en) * 1998-01-27 1999-07-29 Eli Lilly And Company Vegf related gene and protein
DE69939374D1 (de) * 1998-03-17 2008-10-02 Genentech Inc Zu vegf und bmp1 homologe polypeptide
EP0984063A3 (de) * 1998-08-31 2000-08-16 Eli Lilly And Company Vegf-verwandtes gen und protein

Also Published As

Publication number Publication date
CA2356009A1 (en) 2000-06-29
DE69936733D1 (de) 2007-09-13
EP1141293B1 (de) 2007-08-01
DK1141293T3 (da) 2007-11-12
AU2712400A (en) 2000-07-12
IL143832A0 (en) 2002-04-21
CA2356009C (en) 2011-09-20
DE69936733T2 (de) 2008-06-05
EP1141293A2 (de) 2001-10-10
AU778412B2 (en) 2004-12-02
WO2000037641A2 (en) 2000-06-29
WO2000037641A3 (en) 2000-10-19
ES2291047T3 (es) 2008-02-16
NZ512892A (en) 2003-08-29

Similar Documents

Publication Publication Date Title
DE60011100D1 (de) Als cox-hemmer verwendbare sulfonylphenylpyrazol-verbindungen
DE60018105D1 (de) Polypeptidzusammensetzungen mit verbesserter stabilität
AU2019502A (en) Anilinopyrimidine derivatives as ikk inhibitors and compositions and methods related thereto
EA200300171A1 (ru) Циклопентаноиндолы, композиции, содержащие данные соединения, и способы лечения
DE60025369D1 (de) Unterchlorige säure enthaltendes superoxidiertes wasser zur behandlung von wunden
DK0634927T3 (da) Behandling og profylakse af sygdomme forårsaget af parasitter eller bakterier
BR0108452A (pt) Inibidores da oxidação parcial de ácido graxo no tratamento de insuficiência cardìaca congestiva
NO20002440D0 (no) Hydroksam- og karboksylsyrederivater med MMP- og TNF- inhiberende aktivitet
EA200201214A1 (ru) Замещенные тиоацетамиды
DE60126266D1 (de) Verfahren zur oligomerisierung von alkenen
DE60110438D1 (de) Zusammensetzungen enthaltend stilbenoide mit einer hypoglykämischen wirkung
ATE368739T1 (de) Vaskulärer endothelialer wachstumsfaktor x
DE69205859D1 (de) Verwendung von oberflächenaktiven Mitteln zur Verbesserung des Rückflusses von Venenkathetern.
NO994565D0 (no) Lösninger av propionsyre, ammoniakk, propandiol og vann og deres anvendelse
SE0100326D0 (sv) New compounds
ATE256461T1 (de) Benutzung von comt-inhibitoren als analgetika
BR0014990A (pt) Derivados de tetrahidrotiopirano ranftalazinona como inibidores de pde4
PT1242410E (pt) Compostos novos
DE59009945D1 (de) Mittel zur hemmung von hiv-proteasen.
EA200200948A1 (ru) Лечение псориаза
SE0003795D0 (sv) Pharmaceutically useful compounds
DE60022125D1 (de) Tiefstkühlen von Waren
DE60228134D1 (de) Substituierte hydrazone als hemmer von cyclooxygenase-2
ATE324905T1 (de) Verwendung von plgf zur vorbeugung oder behandlung von ischaemie oder schlaganfall
DE60043228D1 (de) Herstellungsverfahren von 2-cyanopyridinen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties